Immunization; Infection Clinical Trial
Official title:
A Phase I/II Study Of The Immunogenicity Of The Yellow Fever Vaccine 17D (YFVax®) In Adults With Prior 17D Vaccination
The goal of this clinical trial is to assess the immune response to the yellow fever vaccine 17D in adults with prior 17D vaccination. The main questions this study aims to answer are: - how does prior vaccination affect antibody responses to re-vaccination? - how does prior vaccination affect the immune cell response to re-vaccination? Participants will: - have been previously vaccinated with 17D. - be re-vaccinated with 17D. - provide medical and travel histories. - provide a blood sample prior to vaccination - provide a blood sample approximately every other day for 14 days after vaccination. - provide a blood sample approximately 28 days after vaccination. - complete a daily diary of symptoms following vaccination for 14 days. - report any additional symptoms after 14 days.
In this study the investigators use 17D revaccination as a live-virus challenge to test the hypothesis that neutralizing antibody titers correlate with YFV protection. The investigators will prospectively characterize pre-boost antibodies titers, vaccine viremia, acute immune responses and post-boost titers in vaccinees receiving boost 17D vaccinations. The investigators expect to identify neutralizing antibody titers above which sterilizing immunity is conferred and titers below which it is not. These Aims will set a foundation for future studies to further dissect determinants of 17D and other live-attenuated vaccine induced immunity and establish metrics that could allow efficient prioritization of 17D vaccination and optimize 17D use in the face of current and future outbreaks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
| Completed |
NCT04042246 -
Effect of Knowledge on Vaccine Take-up in Adamawa State, Northeastern Nigeria
|
N/A | |
| Enrolling by invitation |
NCT05570630 -
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
|
N/A | |
| Completed |
NCT03145324 -
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
|
||
| Recruiting |
NCT06185647 -
Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis
|
||
| Recruiting |
NCT05215327 -
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
|
Phase 2 | |
| Completed |
NCT03355989 -
Evaluation of Conditional Cash Transfers (CCTs) for Immunization
|
N/A | |
| Completed |
NCT02992925 -
Phase 3 Study of BK1310 in Healthy Infants
|
Phase 3 | |
| Completed |
NCT03121638 -
Safety Study of NBP608 in Healthy Adult Volunteers
|
Phase 1 | |
| Not yet recruiting |
NCT05171946 -
Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
|
Phase 1 | |
| Completed |
NCT05661890 -
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
|
||
| Active, not recruiting |
NCT04444518 -
Increasing Influenza and Tdap Vaccination of Pregnant Women
|
N/A | |
| Active, not recruiting |
NCT03908164 -
Optimising the Timing of Whooping Cough Immunisation in MUMs
|
Phase 4 | |
| Completed |
NCT03379467 -
Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage
|
N/A | |
| Not yet recruiting |
NCT03402646 -
Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study
|
N/A | |
| Completed |
NCT04824638 -
BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers
|
Phase 2 | |
| Recruiting |
NCT05774093 -
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
|
||
| Completed |
NCT03083158 -
Immunity to Hepatitis B Vaccine
|
Phase 4 | |
| Recruiting |
NCT04816760 -
Immune Cells Phenotypes During COVID-19
|
||
| Completed |
NCT04870021 -
Hepatitis B Birth Dose for Newborns
|
Phase 4 |